Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 29.05.2026 QMAR.LN IE0006S0EBF2 50,002.00 USD 1,246,084.38 24.921  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 29.05.2026 FTAI IE000YIQZ0H6 200,002.00 USD 6,374,917.80 31.874  ...

デラウェア州ウィルミントン--(BUSINESS WIRE)--（ビジネスワイヤ） -- インサイト（Nasdaq：INCY）は、未治療のびまん性大細胞型B細胞リンパ腫（DLBCL）または高悪性度B細胞リンパ腫（HGBL）の成人患者に対する一次治療として、R-CHOP単独療法を対照に、R-CHOP（リツキシマブ、シクロホスファミド、ドキソルビシン、ビンクリスチン、プレドニゾン）にタファシタマブ（Monjuvi®/Minjuvi®）およびレナリドミドを追加した併用療法（Tafa-Len-R-CHOP）の有効性および安全性を評価したピボタル第3相frontMIND試験で、良好な結果が得られたと発表しました。タファシタマブは、細胞溶解作用を有するFc改変型ヒト化抗CD19モノクローナル抗体です。適格患者は、国際予後指標（IPI）スコアが3～5、または60歳以下の患者では年齢調整IPI（aaIPI）スコアが2～3でした。 これらのデータは、2026年5月29日～6月2日にシカゴで開催される2026年米国臨床腫瘍学会（ASCO）年次総会で口頭発表されるとともに、The Lancetにも同時掲載...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 29.05.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,795,279.41 25.302  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 29.05.2026 QDEC.LN IE000GAKWFA7 450,002.00 USD 10,964,607.71 24.366  ...

WILMINGTON, Del.--(BUSINESS WIRE)--  Die zulassungsrelevante frontMIND-Studie von Incyte zeigte, dass die Kombination mit Tafasitamab (Monjuvi®/Minjuvi®) das progressionsfreie Überleben signifikant verlängerte und das Risiko eines Krankheitsfortschritts oder des Todes bei Patienten mit zuvor unbehandeltem, hochriskantem diffusen, großzelligen B-Zell-Lymphom (DLBCL) um 25 % senkte Incyte (Nasdaq:INCY) gab heute positive Ergebnisse der zulassungsrelevanten Phase-3-Studie frontMIND bekannt, in der...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Europe Infrastructure UCITS ETF 29.05.2026 FTEI.LN IE000TIZ5AP4 200,002.00 EUR 4,169,317.82 20.846  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 29.05.2026 LEGR LN IE00BF5DXP42 950,002.00 USD 52,169,510.52 54.915  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...